Last reviewed · How we verify
premixed insulin analogues
Premixed insulin analogues combine rapid-acting and intermediate-acting insulins to manage blood glucose levels in diabetes.
Premixed insulin analogues combine rapid-acting and intermediate-acting insulins to manage blood glucose levels in diabetes. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus.
At a glance
| Generic name | premixed insulin analogues |
|---|---|
| Sponsor | Xiangya Hospital of Central South University |
| Drug class | Insulin |
| Modality | Small molecule |
| Therapeutic area | Diabetes |
| Phase | Phase 3 |
Mechanism of action
These insulins provide both immediate and sustained glucose-lowering effects, mimicking the natural insulin response more closely than traditional insulins.
Approved indications
- Type 1 diabetes mellitus
- Type 2 diabetes mellitus
Common side effects
- Hypoglycemia
Key clinical trials
- A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus (PHASE4)
- Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy (PHASE3)
- Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |